Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 3
2017 3
2018 3
2019 5
2020 4
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival.
Novak R, Ahmad YA, Timaner M, Bitman-Lotan E, Oknin-Vaisman A, Horwitz R, Hartmann O, Reissland M, Buck V, Rosenfeldt M, Nikomarov D, Diefenbacher ME, Shaked Y, Orian A. Novak R, et al. Among authors: timaner m. Cell Death Dis. 2022 Sep 24;13(9):820. doi: 10.1038/s41419-022-05262-1. Cell Death Dis. 2022. PMID: 36153321 Free PMC article.
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors.
Benguigui M, Vorontsova A, Timaner M, Levin S, Haj-Shomaly J, Deo A, Menachem R, Manobla B, Cooper TJ, Raviv Z, Shaked Y. Benguigui M, et al. Among authors: timaner m. Front Immunol. 2022 Jul 7;13:903591. doi: 10.3389/fimmu.2022.903591. eCollection 2022. Front Immunol. 2022. PMID: 35874722 Free PMC article.
IL-31 induces antitumor immunity in breast carcinoma.
Kan T, Feldman E, Timaner M, Raviv Z, Shen-Orr S, Aronheim A, Shaked Y. Kan T, et al. Among authors: timaner m. J Immunother Cancer. 2020 Aug;8(2):e001010. doi: 10.1136/jitc-2020-001010. J Immunother Cancer. 2020. PMID: 32843492 Free PMC article.
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
Timaner M, Letko-Khait N, Kotsofruk R, Benguigui M, Beyar-Katz O, Rachman-Tzemah C, Raviv Z, Bronshtein T, Machluf M, Shaked Y. Timaner M, et al. Cancer Res. 2018 Mar 1;78(5):1253-1265. doi: 10.1158/0008-5472.CAN-17-1547. Epub 2018 Jan 4. Cancer Res. 2018. PMID: 29301792 Free PMC article.
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy.
Haj-Shomaly J, Vorontsova A, Barenholz-Cohen T, Levi-Galibov O, Devarasetty M, Timaner M, Raviv Z, Cooper TJ, Soker S, Hasson P, Weihs D, Scherz-Shouval R, Shaked Y. Haj-Shomaly J, et al. Among authors: timaner m. Cancer Res. 2022 Jan 15;82(2):278-291. doi: 10.1158/0008-5472.CAN-21-1012. Epub 2021 Oct 19. Cancer Res. 2022. PMID: 34666995 Free PMC article.
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy.
Beyar-Katz O, Magidey K, Reiner-Benaim A, Barak N, Avivi I, Cohen Y, Timaner M, Avraham S, Hayun M, Lavi N, Bersudsky M, Voronov E, Apte RN, Shaked Y. Beyar-Katz O, et al. Among authors: timaner m. Mol Cancer Res. 2019 Nov;17(11):2331-2340. doi: 10.1158/1541-7786.MCR-19-0487. Epub 2019 Aug 13. Mol Cancer Res. 2019. PMID: 31409628
Dequalinium blocks macrophage-induced metastasis following local radiation.
Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y. Timaner M, et al. Oncotarget. 2015 Sep 29;6(29):27537-54. doi: 10.18632/oncotarget.4826. Oncotarget. 2015. PMID: 26348470 Free PMC article.
The antiangiogenic role of the pro-inflammatory cytokine interleukin-31.
Davidi S, Fremder E, Kan T, Raviv Z, Timaner M, Karin N, Hershkovitz D, Arohneim A, Shaked Y. Davidi S, et al. Among authors: timaner m. Oncotarget. 2017 Mar 7;8(10):16430-16444. doi: 10.18632/oncotarget.14857. Oncotarget. 2017. PMID: 28147314 Free PMC article.
21 results